FKRP and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: Mutations causing loss of function in FKRP lead to a broad spectrum of dystroglycanopathy-associated symptoms, primarily affecting the development of the muscles and heart, but also the brain and eyes.